For unexplained reasons, KRAS mutations are predominantly found in pancreatic cancer, colorectal cancer, and adenocarcinoma of the lung, whereas mutated NRAS is predominantly found in a subset of acute leukemias and in myelodysplastic syndromes [19]. This evidence concerns the gene KRAS and familial pancreatic carcinoma.